s6y
Company name or ticker
Search
Foghorn Therapeutics Inc.
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filed
Friday, August 28, 2020
Accession number
0000950123-20-009426
Documents
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS
Exhibits
4.2
Terms of securities
EX-4.2
4.3
Terms of securities
EX-4.3
4.4
Terms of securities
EX-4.4
10.1
Material contract
EX-10.1
10.2
Material contract
EX-10.2
10.3
Material contract
EX-10.3
10.4
Material contract
EX-10.4
10.5
Material contract
EX-10.5
10.6
Material contract
EX-10.6
10.7
Material contract
EX-10.7
10.9
Material contract
EX-10.9
10.10
Material contract
EX-10.10
10.11
Material contract
EX-10.11
21.1
Subsidiaries
EX-21.1
On sec.gov
Filing index
All files
Complete submission text
SGML header